Particularly, lesion expression of the estrogen receptor (ER), progesterone receptor (PR), HER2 and Ki-67 have been identified as promising biomarkers to monitor the progression of invasive breast cancers in humans [16,17,18]. The gene discussed is ESR1; the disease is invasive breast carcinoma.